A

fter months of intrigue and intense political jockeying, the European Council voted on Monday to relocate Europe’s top medicines regulator to Amsterdam from London.

The close vote — a coin toss was needed — means the European Medicines Agency is likely to encounter less disruption than if Milan, the runner-up, had been chosen. A recent survey of agency staffers favored Amsterdam for its superior international flight service and schools, suggesting the EMA will be able to retain enough staff to maintain regular activities during the upcoming transition.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Biotech newsletter — The Readout

Your daily guide to what’s new in biotech.